Arvinas (NASDAQ:ARVN) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.95) by 28.42 percent. The company reported quarterly sales of $102.400 which missed the analyst consensus estimate of $57.421 million by 100.00 percent. This is a 100.00 percent decrease over sales of $34.600 million the same period last year.